Ballentine Partners, LLC Karuna Therapeutics, Inc. Transaction History

Ballentine Partners, LLC

  • $5.39 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023
SELL
$176.32 - $240.22 $135,413 - $184,488
-768 Reduced 35.38%
1,403 $304,000
Q1 2023

Apr 27, 2023
BUY
$161.33 - $204.36 $85,182 - $107,902
528 Added 32.14%
2,171 $394,000
Q4 2022

Jan 27, 2023
BUY
$191.53 - $236.82 $92,508 - $114,384
483 Added 41.64%
1,643 $0
Q3 2022

Oct 26, 2022
BUY
$123.79 - $277.42 $143,596 - $321,807
1,160 New
1,160 $261,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email